[Pharmacological and clinical profile of tiotropium bromide (Spiriva), a new long-acting anticholinergic bronchodilator for COPD treatment]

Nihon Yakurigaku Zasshi. 2005 May;125(5):307-13. doi: 10.1254/fpj.125.307.
[Article in Japanese]
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Bronchoconstriction / drug effects
  • Bronchodilator Agents / administration & dosage
  • Bronchodilator Agents / therapeutic use*
  • Cholinergic Antagonists / administration & dosage
  • Cholinergic Antagonists / therapeutic use*
  • Humans
  • Pulmonary Disease, Chronic Obstructive / drug therapy*
  • Quality of Life
  • Receptors, Muscarinic / drug effects
  • Scopolamine Derivatives / administration & dosage
  • Scopolamine Derivatives / pharmacology*
  • Scopolamine Derivatives / therapeutic use*
  • Tiotropium Bromide

Substances

  • Bronchodilator Agents
  • Cholinergic Antagonists
  • Receptors, Muscarinic
  • Scopolamine Derivatives
  • Tiotropium Bromide